C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/04 (2006.01) A61K 31/44 (2006.01) A61P 3/04 (2006.01) A61P 9/00 (2006.01) A61P 29/00 (2006.01) C07D 401/14 (2006.01) C07D 413/14 (2006.01)
Patent
CA 2756250
Mineralocorticoid receptor antagonists (MRa), pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat, for example, diabetic nephropathy and hypertension in mammals, including humans.
La présente invention concerne des antagonistes de récepteur minéralocorticoïde (MRa), des compositions pharmaceutiques contenant de tels inhibiteurs et l'utilisation de tels inhibiteurs pour traiter, par exemple, une néphropathie diabétique et l'hypertension chez des mammifères, comprenant les humains.
Arhancet Graciela Barbieri
Casimiro-Garcia Agustin
Chen Xiangyang
Hepworth David
Meyers Marvin Jay
Pfizer Inc.
Torys Llp
LandOfFree
4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1358370